Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziding Feng

Showing results (241-250 of 288) with videos related to

Pageof 29
Sort By:
Radiology|January 24, 2023
Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular CarcinomaTakeshi Yokoo, Nobuaki Masaki, Neehar D Parikh, et al.
Plos One|July 15, 2015
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 PatientsJames D Brooks, Wei Wei, Sarah Hawley, et al.
Oncogene|April 13, 2005
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression riskKarsten Schulmann, Anca Sterian, Agnes Berki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?John T Wei, Ziding Feng, Alan W Partin, et al.
European Urology Focus|September 13, 2016
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate CancerTamara L Lotan, Wei Wei, Carlos L Morais, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 4, 2012
Prevalidation of salivary biomarkers for oral cancer detectionDavid Elashoff, Hui Zhou, Jean Reiss, et al.
Gastroenterology|November 14, 2025
Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma ScreeningNicole J Kim, Muyi Li, Philip Vutien, et al.
Plos One|November 16, 2016
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional StudyOkyaz Eminaga, Wei Wei, Sarah J Hawley, et al.
Hepatology (Baltimore, Md.)|December 19, 2024
Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panelAmit G Singal, Lisa Quirk, Justin Boike, et al.
Thoracic Cancer|July 8, 2016
Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot studyDan Pu, Hao Liang, Fang Wei, et al.
Pageof 29

Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
Radiology|January 24, 2023
Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular CarcinomaTakeshi Yokoo, Nobuaki Masaki, Neehar D Parikh, et al.
Plos One|July 15, 2015
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 PatientsJames D Brooks, Wei Wei, Sarah Hawley, et al.
Oncogene|April 13, 2005
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression riskKarsten Schulmann, Anca Sterian, Agnes Berki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?John T Wei, Ziding Feng, Alan W Partin, et al.
European Urology Focus|September 13, 2016
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate CancerTamara L Lotan, Wei Wei, Carlos L Morais, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 4, 2012
Prevalidation of salivary biomarkers for oral cancer detectionDavid Elashoff, Hui Zhou, Jean Reiss, et al.
Gastroenterology|November 14, 2025
Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma ScreeningNicole J Kim, Muyi Li, Philip Vutien, et al.
Plos One|November 16, 2016
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional StudyOkyaz Eminaga, Wei Wei, Sarah J Hawley, et al.
Hepatology (Baltimore, Md.)|December 19, 2024
Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panelAmit G Singal, Lisa Quirk, Justin Boike, et al.
Thoracic Cancer|July 8, 2016
Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot studyDan Pu, Hao Liang, Fang Wei, et al.
Pageof 29